Vincerx Pharma, Inc. Profile Avatar - Palmy Investing

Vincerx Pharma, Inc.

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibit…

Biotechnology
US, Palo Alto [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Vincerx Pharma, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Vincerx Pharma, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Vincerx Pharma, Inc..

End of VINC's Analysis
CIK: 1796129 CUSIP: 92731L106 ISIN: US92731L1061 LEI: - UEI: -
Secondary Listings
VINC has no secondary listings inside our databases.